ARCHIVES

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Mesothelioma Survival, QOL Improved With Alimta, Platinol

March 28, 2003

Shingleton To Retire As Director Of Duke Comprehensive Center

July 10, 1981

NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned.

July 16, 2004

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999

Liver Transplant Associated With 67% 5-Year Survival

February 23, 2007